Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Basiliximab Maintenance in Ulcerative Colitis

This study has been terminated.
(lack of efficacy)
Sponsor:
Information provided by:
Cerimon Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01061996
First received: February 2, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)